Klaria Pharma’s CEO to present the company on March 12 in Stockholm
Klaria Pharma Holding AB (publ) announces that CEO Jesper Wiklund will hold a company presentation on Klaria as a part of Erik Penser Bank’s Company Day event on March 12, 2020 in Stockholm, Sweden.
The presentation will, among other things, include Klaria’s new focused development strategy to maximize shareholder value and the pivotal clinical study for the company’s EU Horizon 2020-financed Sumatriptan Alginate Film scheduled for 2020.
There is no admission fee for attending the event, but the number of seats is limited. Registration is handled via Erik Penser Bank’s website, www.penser.se, where more information and the complete schedule for the event will be published shortly.
